Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | E120* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CDKN2A E120* results in a premature truncation of the Cdkn2a protein at amino acid 120 of 156 (UniProt.org). E120* is predicted to confer a loss of function to the Cdkn2a protein, as demonstrated by a loss of Cdk binding in an in vitro assay (PMID: 8668202). |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A E120* |
Transcript | NM_000077.5 |
gDNA | chr9:g.21971001C>A |
cDNA | c.358G>T |
Protein | p.E120* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001195132 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_047422598.1 | chr9:g.21970450C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_047422596.1 | chr9:g.21970450C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077.4 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517676 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517676.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_000077 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517675 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.21971001C>A | c.358G>T | p.E120* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|